LIWANLI Innovation Co., Ltd. (3054) Stock Price & Analysis
3054 Stock Chart & Stats
- Day’s Range
- TWD 52.30 - TWD 55.90
- 52-Week Range
- TWD 22.00 - TWD 96.00
- Previous Close
- TWD 55.90
- Volume
- N/A
- Average Volume (3M)
- 112.45K
- Market Cap
- TWD 4.25B
- Enterprise Value
- TWD 3.83B
- Total Cash (Recent Filing)
- TWD 976.32M
- Total Debt (Recent Filing)
- TWD 912.00K
- Price to Earnings (P/E)
- 6.1
- Beta
- 0.49
- Next Earnings
- Mar 02, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jun 26, 2026
- Dividend Yield
- 1.48%
3054 FAQ
What was LIWANLI Innovation Co., Ltd.’s price range in the past 12 months?
What is LIWANLI Innovation Co., Ltd.’s market cap?
When is LIWANLI Innovation Co., Ltd.’s upcoming earnings report date?
How were LIWANLI Innovation Co., Ltd.’s earnings last quarter?
Is LIWANLI Innovation Co., Ltd. overvalued?
Does LIWANLI Innovation Co., Ltd. pay dividends?
What is LIWANLI Innovation Co., Ltd.’s EPS estimate?
How many shares outstanding does LIWANLI Innovation Co., Ltd. have?
What happened to LIWANLI Innovation Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of LIWANLI Innovation Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
LIWANLI Innovation Co., Ltd.
LIWANLI Innovation Co., Ltd. operates within the biomedical science sector, concentrating on the development and distribution of nutrition and healthcare solutions. The company's diverse product portfolio, which notably features the Vigoway line and various powdered formulations, is designed to serve a wide range of consumers, including men, women, seniors, and children. Its extensive offerings encompass products such as probiotic enzymes, active nutrients, resveratrol red grape extract, and a variety of soft gels (including those with algae DHA, shea butter with type II collagen, and algae astaxanthin Q10). Other specialized items include cordyceps militaris powder, tooth guard tablets, bovine and goat's milk bites, bilberry tablets, and DHA and vitamin D3 drops, among others. The firm was formerly known as Carry Technology International Co., Ltd. before officially adopting its current name, LIWANLI Innovation Co., Ltd., in 2015. Established in 1980, the company's headquarters are located in New Taipei City, Taiwan.
- Sector
- General
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Li-Ching Chen
- Employees
- 360
- Website
- www.liwanli.com.tw
- Address
- No. 537, Tanmei St., Taipei, TP, 114, TW
LIWANLI Innovation Co., Ltd. (3054) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 4 | 13 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 1 | 0 | 11 |

